Insider Cluster (2 insiders) ·Filed Jul 6, 2026

PCVX

Vaxcyte, Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed2mo ago
Insider cluster: 2 insiders, $389K total
Actionable Insight • Neutral

Selling is trivial in size and likely driven by routine portfolio diversification or tax planning. No actionable signal—monitor for any future material insider purchases or changes in selling patterns.

DirectionNeutral
Confidencehigh
Horizonimmediate
Final — all horizons settled through T+60d ⚠ clustered
PCVX ▼ -6.21% at T+60d
NEUTRAL call ✗ call lost -6.21% · α vs SPY -8.21% · entry $60.67 → $56.90
Entry anchored
Jul 6, 03:59 PM ET
via exchange tick
T+1d
-3.23%
call -3.23% · α -2.92%
$58.71
settled 3mo ago
T+5d
-7.35%
call -7.35% · α -7.90%
$56.21
settled 3mo ago
T+20d
-11.77%
call -11.77% · α -13.10%
$53.53
settled 2mo ago
T+60d
-6.21%
call -6.21% · α -8.21%
$56.90
settled 3d ago

Price Chart

Loading chart...

Executive Summary

Insider selling cluster at Vaxcyte (PCVX): CEO Grant Pickering sold $363K and COO Jim Wassil sold $26K in open-market trades, totaling $389K over a 7-day window. The dollar amount is negligible relative to the $8.4B market cap (0.0046%), making this a routine, non-informative event.

Key Financial Metrics

Direction
selling
Total Value
$389.0K
Insiders
2

Key Facts

  • CEO Grant Pickering sold 6,700 shares for ~$363K at $54.27 on 2026-06-26.
  • COO Jim Wassil sold 2,250 shares (including 1,788 after derivative exercise) for ~$126K at $56.03–$57.47 on 2026-07-01.
  • Total cluster value of $389K is 0.0046% of PCVX's $8.4B market cap.
  • No insider purchases in the cluster; all transactions are open-market sales or derivative exercises followed by sales.

Financial Impact

Insider sales of $389K, immaterial relative to market cap of $8.4B.

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
88% bullish (17 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-PCVX-1783378885585
13 reports for PCVX
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for PCVX — sortable, filterable
TypeNow
Aug 5, 2026
8w ago
Insider Cluster
NEUTRAL ★ 2/10
$55.92 $61.58▲ +10.12%▲ +10.72%$56.69 (+1.38%)
Jul 6, 2026
12w ago
Insider Cluster
NEUTRAL ★ 2/10
$60.67 $53.53▼ −11.77%▼ −13.10%$56.69 (−6.56%)
Jul 6, 2026
12w ago
Insider Cluster
NEUTRAL ★ 2/10
$60.67 $53.53▼ −11.77%▼ −13.10%$56.69 (−6.56%)
Jun 26, 2026
13w ago
144
NEUTRAL ★ 3/10
$57.72 $54.66▼ −5.30%▼ −5.02%$56.69 (−1.78%)
Jun 23, 2026
14w ago
8-K
NEUTRAL ★ 2/10
$53.87 $56.00▲ +3.95%▲ +2.02%$56.69 (+5.23%)
Jun 19, 2026
15w ago
Insider Cluster
NEUTRAL ★ 3/10
$52.11 $56.20▲ +7.85%▲ +8.00%$56.69 (+8.79%)
Jun 2, 2026
17w ago
Press Release
NEUTRAL ★ 4/10
$46.93 $58.39▲ +24.42%▲ +25.42%$56.69 (+20.80%)
May 6, 2026
21w ago
8-K
BEARISH ★ 7/10
$51.48 $46.93▲ +8.84%▲ +11.97%$56.69 (−10.12%)
Apr 23, 2026
23w ago
DEFA14A
NEUTRAL ★ 3/10
$59.49 $47.39▼ −20.34%▼ −24.37%$56.69 (−4.71%)
Apr 1, 2026
26w ago
Insider Cluster
NEUTRAL ★ 3/10
$58.50 $57.32▼ −2.02%▼ −11.74%$56.69 (−3.09%)
Showing 10 of 13

US Market Status

Market Open — Closes in 3h 56m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Jul 6, 2026